✦ LIBER ✦

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

✍ Scribed by E. C. Nista; M. Candelli; F. Cremonini; I. A. Cazzato; M. A. Zocco; F. Franceschi; G. Cammarota; G. Gasbarrini; A Gasbarrini

Book ID: 108603885
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 95 KB
Volume: 20
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2004.02274.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lactobacillus reuteri therapy to reduce

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial

✍ E. LIONETTI; V. L. MINIELLO; S. P. CASTELLANETA; A. M. MAGISTÁ; A. DE CANIO; G. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Healing of lymphocytic gastritis after H

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double-blind, placebo-controlled multicentre trial

✍ A. MADISCH; S. MIEHLKE; F. NEUBER; A. MORGNER; E. KUHLISCH; S. RAPPEL; N. LEHN; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Sildenafil adjunctive therapy to risperi

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

✍ Shahin Akhondzadeh; Raofeh Ghayyoumi; Farzin Rezaei; Bahman Salehi; Amir-Hossein 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 154 KB

Antiemetic control and prevention of sid

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

✍ Dr. Mark G. Kris; Richard J. Gralla; Rebecca A. Clark; Leslie B. Tyson; Susan Gr 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

Rituximab for rheumatoid arthritis refra

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

✍ Stanley B. Cohen; Paul Emery; Maria W. Greenwald; Maxime Dougados; Richard A. Fu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 3 views

Very early treatment with infliximab in

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

✍ Mark A. Quinn; Philip G. Conaghan; Philip J. O'Connor; Zunaid Karim; Adam Greens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views